NCT06988865View on ClinicalTrials.gov

Benign Migratory Glossitis Associated With Antiangiogenic Drugs

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

July 16, 2017

Primary Completion Date

January 10, 2020

Study Completion Date

February 1, 2024

Conditions
CancerGeographic Tongue
Interventions
OTHER

Clinical evaluation

treatment methods, associated symptoms, evolution and clinical presentation

Trial Locations (1)

01246-000

Instituto do Cancer do Estado de São Paulo, São Paulo

All Listed Sponsors
lead

Instituto do Cancer do Estado de São Paulo

OTHER

NCT06988865 - Benign Migratory Glossitis Associated With Antiangiogenic Drugs | Biotech Hunter | Biotech Hunter